arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Elicio Therapeutics, Inc.

ELTX

$3.17 ▲ +0.03 (+0.95%) at close

26 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Elicio Therapeutics, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $57.7M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -104.2% ↘

FCF / Share $-0.64

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -6.59

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-11.82M

↓ -5.5% —

FCF / Share Free cash flow per share

$-0.64

↑ +18.2% —

Long-Term Debt Long-term obligations

$9.47M

↓ -5.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Financial Health

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	N/M	—	N/M	20.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+162%)	344.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4203%)	5551.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+69295%)	76.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+857%)	-25.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-424%)	-57.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-814%)	—	—	—	—	—
EPS Growth YoY (%)	25.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	52.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	56.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	24.3% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-385.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-9.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	73.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-666.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	99.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-323.3% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-713.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	68.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	43.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	48.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	69.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	55.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	58.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-71.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-5.5% Weak ↓ Weak Declining Year-over-year change in net income	44.9% Excellent ↑ Excellent Improving Year-over-year change in net income	5.2% Fair ↑ Fair Improving Year-over-year change in net income	5.2% Fair ↑ Fair Improving Year-over-year change in net income	5.2% Fair ↑ Fair Improving Year-over-year change in net income	-56.5% Weak ↑ Weak Improving Year-over-year change in net income	-47.3% Weak ↑ Weak Improving Year-over-year change in net income	-47.3% Weak ↑ Weak Improving Year-over-year change in net income	-160.7% Weak ↓ Weak Declining Year-over-year change in net income	-34.6% Weak ↓ Weak Declining Year-over-year change in net income	43.6% Excellent ↓ Excellent Declining Year-over-year change in net income	43.6% Excellent ↑ Excellent Improving Year-over-year change in net income	68.1% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	9.3% Fair ↓ Fair Declining Year-over-year change in net income	61.2% Excellent ↑ Excellent Improving Year-over-year change in net income	61.2% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	11.1% Fair ↑ Fair Improving Year-over-year change in net income	-177.5% Weak Weak Year-over-year change in net income	-177.5% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	18.2% Good Good Year-over-year change in free cash flow	—	—	—	33.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-339.8% Weak Weak Year-over-year change in free cash flow	—	—	—	48.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	2.7% Caution Caution Year-over-year change in free cash flow	—	—	—	11.3% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	56.4% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+276%)	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	57.4% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+378%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-55.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.78x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.10x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	-0.97x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.71x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-104.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-71.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-95.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-122.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	43.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	522.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-166.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-64.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.6% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	14.2% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.2% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	14.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	27.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	32.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-46.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-26.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	15.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-14.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-29.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	—	-293.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2058%)	—	-125.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-939%)	123.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+725%)	62.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+315%)	—	-242.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1719%)	-78.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-625%)	-60.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-503%)	-34.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-327%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	6.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-57%)	-28.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	-23.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-21.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	18.3% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+22%)	-24.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	-47.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-417%)	-39.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	31.9% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+113%)	28.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+86%)	26.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+80%)	43.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+187%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	-6.59x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1199%)	6.11x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+919%)	2.55x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+325%)	5.09x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+749%)	—	-1.77x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-395%)	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-101%)	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	-284.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-10771.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-64.79x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	-9.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-35.46x Weak Weak Operating income divided by interest expense Optimal: > 5x	-69.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-5.47M	$-8.56M	$-10.89M	$-12.75M	$-18.35M	$2.42M	$-26.02M	$-3.42M	$-11.85M	$-12.89M	$-14.84M	$-21.68M	$-29.22M	$-6.16M	$-55.14M	$-63.37M	$-73.00M	$-88.76M	$-102.74M	$-117.31M	$-130.46M	$-33.97M	—	—	—	—
Debt / EBITDA (x)	-0.90x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.14x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.22x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.50x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	$0.00	$0.02	$0.06	—	$0.05	$0.02	$0.02	—	$0.06	$0.05	$0.06	—
Basic EPS, GAAP (USD)	$-0.65	$-0.49	$-0.60	$-0.66	$-0.87	$-1.02	$-1.39	$-0.64	$-1.15	$-0.21	$-1.27	$-2.44	$-0.15	$-20.75	$-0.30	$-0.30	$-0.48	$0.58	$-0.53	$-0.58	$-1.56	$-1.92	$-1.19	$-1.40	$-0.91	—
Free Cash Flow per Share (USD)	$-0.64	—	$-0.66	$-0.56	$-0.78	—	—	—	$-1.18	—	—	—	$-0.27	—	—	—	$-0.52	—	—	—	$-0.54	—	$-1.48	$-0.88	$-0.61	—
Book Value per Share (USD)	$-0.08	$0.09	$0.22	$0.11	$0.56	$-1.03	$-1.76	$-0.16	$0.48	$1.18	$1.59	$2.81	$1.32	$-318.92	$1.67	$1.99	$2.24	$2.72	$2.16	$2.59	$3.12	$-5.91	$-4.26	$-3.38	$-2.12	—
Tangible Book Value per Share (USD)	$-0.08	$0.09	$0.22	$0.11	$0.56	$-1.03	$-1.76	$-0.16	$0.48	$1.18	$1.59	$2.81	$1.32	$-318.92	$1.67	$1.99	$2.24	$2.72	$2.16	$2.59	$3.12	$-5.91	$-4.26	$-3.38	$-2.12	—
Basic Weighted Avg Shares (shares)	18.21M	—	16.69M	16.06M	12.95M	—	13.58M	11.28M	10.27M	—	8.38M	3.10M	30.11M	—	30.11M	29.97M	29.96M	—	29.83M	29.67M	23.44M	—	14.85M	14.51M	14.46M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$8.97M	$11.20M	$14.95M	$12.68M	$9.52M	$9.17M	$21.63M	$-896.00K	$8.18M	$6.59M	$8.45M	$18.63M	$38.60M	$3.85M	$48.50M	$58.10M	$65.86M	$79.95M	$86.45M	$99.18M	$116.53M	$-65.15M	—	—	—	—
LT Debt (USD)	$9.47M	$10.00M	$9.72M	$9.34M	—	$20.03M	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	$635.00K	—	—	—	—
Total Equity (USD)	$-1.44M	$1.64M	$3.82M	$1.83M	$8.90M	$-11.31M	$-18.99M	$-1.65M	$4.87M	$11.37M	$13.29M	$23.56M	$39.67M	$-102.14M	$50.21M	$59.76M	$67.20M	$81.51M	$64.51M	$77.19M	$92.44M	$-90.45M	$-63.19M	$-49.10M	$-30.68M	$-18.59M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	$0.00	$653.00K	$1.65M	$25.94M	$1.46M	$540.00K	$371.00K	$459.00K	$827.00K	$729.00K	$865.00K	—
Depreciation Expense (USD)	$46.00K	$49.00K	$100.00K	$100.00K	$53.00K	$85.00K	$0.00	—	$82.00K	$80.00K	$0.00	—	$22.00K	$100.00K	—	—	$32.00K	$32.00K	$23.00K	$23.00K	$6.00K	$12.00K	$47.00K	$47.00K	$27.00K	—
Net Income, GAAP (USD)	$-11.82M	$-7.72M	$-11.21M	$-11.21M	$-11.21M	$-14.00M	$-11.83M	$-11.83M	$-11.83M	$-8.95M	$-8.03M	$-8.03M	$-4.54M	$-6.65M	$-14.24M	$-14.24M	$-14.24M	$14.89M	$-15.70M	$-36.69M	$-36.69M	$-28.88M	$-17.67M	$-13.22M	$-13.22M	—
Operating Cash Flow (USD)	$-11.64M	$-6.80M	$-11.09M	$-8.95M	$-10.12M	$-8.74M	—	—	$-12.12M	$-9.89M	—	—	$-8.08M	$-7.28M	—	—	$-15.65M	$-14.36M	—	—	$-12.55M	$20.59M	$-21.94M	$-12.80M	$-8.73M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Elicio Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ELTX with peers